A detailed history of Jane Street Group, LLC transactions in Vericel Corp stock. As of the latest transaction made, Jane Street Group, LLC holds 104,094 shares of VCEL stock, worth $6.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
104,094
Previous 75,057 38.69%
Holding current value
$6.1 Million
Previous $3.44 Million 27.71%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$42.25 - $53.56 $1.23 Million - $1.56 Million
29,037 Added 38.69%
104,094 $4.4 Million
Q2 2024

Aug 14, 2024

BUY
$41.71 - $52.9 $2.71 Million - $3.43 Million
64,871 Added 636.86%
75,057 $3.44 Million
Q1 2024

May 15, 2024

BUY
$32.52 - $52.33 $57,820 - $93,042
1,778 Added 21.15%
10,186 $529,000
Q4 2023

Feb 14, 2024

SELL
$30.85 - $37.09 $46,552 - $55,968
-1,509 Reduced 15.22%
8,408 $299,000
Q3 2023

Nov 14, 2023

SELL
$31.69 - $39.25 $1.13 Million - $1.4 Million
-35,685 Reduced 78.25%
9,917 $332,000
Q2 2023

Aug 14, 2023

SELL
$29.0 - $38.37 $705,483 - $933,426
-24,327 Reduced 34.79%
45,602 $1.71 Million
Q1 2023

May 15, 2023

BUY
$23.85 - $31.34 $1.67 Million - $2.19 Million
69,929 New
69,929 $2.05 Million
Q2 2022

Aug 16, 2022

SELL
$22.88 - $39.45 $168,030 - $289,720
-7,344 Closed
0 $0
Q1 2022

May 17, 2022

SELL
$31.69 - $43.29 $3,200 - $4,372
-101 Reduced 1.36%
7,344 $280,000
Q4 2021

Feb 15, 2022

SELL
$35.2 - $52.6 $1,936 - $2,893
-55 Reduced 0.73%
7,445 $293,000
Q3 2021

Nov 16, 2021

SELL
$46.35 - $59.75 $624,056 - $804,474
-13,464 Reduced 64.22%
7,500 $366,000
Q2 2021

Aug 16, 2021

BUY
$47.2 - $67.81 $745,854 - $1.07 Million
15,802 Added 306.12%
20,964 $1.1 Million
Q1 2021

May 18, 2021

SELL
$30.93 - $59.48 $1.02 Million - $1.96 Million
-32,996 Reduced 86.47%
5,162 $287,000
Q4 2020

Feb 17, 2021

BUY
$18.53 - $31.5 $284,861 - $484,249
15,373 Added 67.47%
38,158 $1.18 Million
Q3 2020

Nov 17, 2020

BUY
$14.68 - $19.12 $31,444 - $40,955
2,142 Added 10.38%
22,785 $422,000
Q2 2020

Aug 17, 2020

BUY
$8.5 - $15.82 $78,812 - $146,683
9,272 Added 81.54%
20,643 $285,000
Q1 2020

May 15, 2020

BUY
$7.25 - $19.22 $82,439 - $218,550
11,371 New
11,371 $104,000
Q4 2018

Feb 15, 2019

SELL
$10.77 - $18.44 $181,689 - $311,082
-16,870 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$9.1 - $14.8 $153,517 - $249,676
16,870 New
16,870 $239,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.77B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.